Northwest Biotherapeutics Closes Acquisition of Advent BioServices
Northwest Biotherapeutics has completed its acquisition of Advent BioServices, making Advent a wholly owned subsidiary, announced in a press release. The company stated that the acquisition will enable operational efficiencies, scale-up of manufacturing, and integration of technologies and intellectual property from both organizations.
As part of the transaction, Northwest Biotherapeutics will acquire all of Advent's fixed assets, including cryostorage and equipment, as well as intellectual property and other intangibles. The company will not issue new shares for the acquisition; instead, 19 million previously issued securities will revert to Northwest Biotherapeutics.
The payment terms include £1.4 million and the net accounts payable due to Advent, to be paid in installments over two years. Installment payments will begin 90 days after the October closing, with potential acceleration following regulatory approval of the DCVax-L product. The integration will also consolidate operations at the Sawston, UK facility and support capacity expansion in the United States.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 KBRA Rated Anthropic BB+ Before $35 Billion Chip Financing Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer BankMore from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsAI Funding Brief
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Sopris Capital Acquires Blackford Analysis from Bayer
Quantum X Signs Deal to Buy 80% of TraderMade
Sunbound Acquires Richter and Raises $24 Million
Vertiv to Acquire King Environmental Services
INmune Bio and QCi Apply Quantum Computing to XPro Research
Daily AI Brief: the AI news that matters, in your inbox.